Chin‐Lee Wu

28.3k total citations · 1 hit paper
247 papers, 8.5k citations indexed

About

Chin‐Lee Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Chin‐Lee Wu has authored 247 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Pulmonary and Respiratory Medicine, 93 papers in Molecular Biology and 62 papers in Surgery. Recurrent topics in Chin‐Lee Wu's work include Prostate Cancer Treatment and Research (58 papers), Prostate Cancer Diagnosis and Treatment (57 papers) and Bladder and Urothelial Cancer Treatments (40 papers). Chin‐Lee Wu is often cited by papers focused on Prostate Cancer Treatment and Research (58 papers), Prostate Cancer Diagnosis and Treatment (57 papers) and Bladder and Urothelial Cancer Treatments (40 papers). Chin‐Lee Wu collaborates with scholars based in United States, China and Canada. Chin‐Lee Wu's co-authors include Shulin Wu, Zhong Jiang, Bruce A. Woda, W. Scott McDougal, Lawrence Zukerberg, Ximing J. Yang, Leo L. Cheng, Aria F. Olumi, Ed Harlow and Robert H. Young and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Chin‐Lee Wu

238 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses

2023 126 citations Shulin Wu, Chin‐Lee Wu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chin‐Lee Wu United States	52	4.2k	2.8k	2.0k	2.0k	1.5k	247	8.5k
David F. Jarrard United States	49	4.0k 1.0×	5.0k 1.8×	2.1k 1.0×	2.0k 1.0×	920 0.6×	207	10.0k
Olivier Kocher United States	46	4.6k 1.1×	3.0k 1.1×	2.9k 1.4×	1.7k 0.9×	1.1k 0.8×	93	9.3k
Peter Birner Austria	49	3.3k 0.8×	2.1k 0.8×	4.0k 2.0×	2.2k 1.1×	1.2k 0.9×	169	9.0k
Silvano Bòsari Italy	56	4.6k 1.1×	1.7k 0.6×	2.8k 1.4×	2.5k 1.3×	1.4k 0.9×	189	9.4k
Dean A. Troyer United States	48	3.1k 0.7×	3.6k 1.3×	1.3k 0.6×	1.3k 0.6×	713 0.5×	150	8.0k
Efthimios Sivridis Greece	55	5.2k 1.2×	1.4k 0.5×	2.6k 1.3×	4.3k 2.2×	952 0.7×	245	10.2k
Iver Petersen Germany	55	5.2k 1.3×	2.4k 0.9×	3.2k 1.6×	2.4k 1.2×	1.0k 0.7×	241	10.4k
Gregor Weirich Germany	40	3.1k 0.7×	4.3k 1.5×	1.2k 0.6×	1.3k 0.6×	907 0.6×	121	7.5k
Dan Theodorescu United States	69	7.5k 1.8×	3.1k 1.1×	3.6k 1.8×	2.8k 1.4×	3.8k 2.6×	335	14.6k
Patrick Pauwels Belgium	60	4.3k 1.0×	3.2k 1.1×	4.2k 2.0×	2.9k 1.5×	925 0.6×	305	10.6k

Countries citing papers authored by Chin‐Lee Wu

Since Specialization

Citations

This map shows the geographic impact of Chin‐Lee Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Lee Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Lee Wu more than expected).

Fields of papers citing papers by Chin‐Lee Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin‐Lee Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Lee Wu. The network helps show where Chin‐Lee Wu may publish in the future.

Co-authorship network of co-authors of Chin‐Lee Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chin‐Lee Wu. A scholar is included among the top collaborators of Chin‐Lee Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin‐Lee Wu. Chin‐Lee Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Booth, Simon, Paul Norris, Gabriel Chow, et al.. (2023). Abstracts. Anaesthesia. 78(S3). 8–66. 2 indexed citations

Townsend, William, Max S. Topp, Michael Dickinson, et al.. (2023). Glofitamab plus immunochemotherapy demonstrates durable efficacy with manageable safety in relapsed/refractory non‐Hodgkin lymphoma (R/R NHL): update of a Phase Ib study. Hematological Oncology. 41(S2). 595–597. 1 indexed citations

Liu, Yanna, Jian Geng, Zhuolin Li, et al.. (2023). Dynamic viral integration patterns actively participate in the progression of BK polyomavirus-associated diseases after renal transplantation. American Journal of Transplantation. 23(11). 1694–1708. 8 indexed citations

Zhu, Xuejin, Yangjia Zhuo, Shulin Wu, et al.. (2021). TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis. Frontiers in Oncology. 11. 632524–632524. 11 indexed citations

Ye, Jian‐Heng, Zhiduan Cai, Yong Luo, et al.. (2020). GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate. Cancer Research. 80(11). 2150–2162. 51 indexed citations

Liu, Junchen, Guo Chen, Zezhen Liu, et al.. (2018). Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer. Cancer Research. 78(16). 4459–4470. 88 indexed citations

Zhang, Jing, Xiongfei Xu, Min Shi, et al.. (2017). CD13^hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. OncoImmunology. 6(2). e1258504–e1258504. 58 indexed citations

Saylor, Philip J., Richard J. Lee, Kshitij S. Arora, et al.. (2016). Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 23(2). 363–369. 22 indexed citations

Giannikou, Krinio, Izabela A. Malinowska, Trevor J. Pugh, et al.. (2016). Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. PLoS Genetics. 12(8). e1006242–e1006242. 85 indexed citations

10.

Singh, Harshabad, Yang Liu, Xiuli Xiao, et al.. (2016). Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations. Oncotarget. 7(20). 29211–29215. 22 indexed citations

11.

Cai, Chao, Zhaodong Han, Yanqiong Zhang, et al.. (2015). miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Clinical Cancer Research. 21(21). 4922–4934. 103 indexed citations

12.

Miyamoto, David T., Richard J. Lee, Shannon L. Stott, et al.. (2012). Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer. Cancer Discovery. 2(11). 995–1003. 217 indexed citations

13.

Passer, Brent J., Tooba A. Cheema, Bingsen Zhou, et al.. (2010). Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication. Cancer Research. 70(10). 3890–3895. 26 indexed citations

14.

Leung, Yuet‐Kin, Hung‐Ming Lam, Shulin Wu, et al.. (2010). Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocrine Related Cancer. 17(3). 675–689. 120 indexed citations

15.

Feldman, Adam S., Jacqueline Banyard, Chin‐Lee Wu, W. Scott McDougal, & Bruce R. Zetter. (2009). Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression. Clinical Cancer Research. 15(3). 1024–1031. 57 indexed citations

16.

Goel, Hira Lal, Loredana Moro, Joanne E. Murphy-Ullrich, et al.. (2009). β1 Integrin Cytoplasmic Variants Differentially Regulate Expression of the Antiangiogenic Extracellular Matrix Protein Thrombospondin 1. Cancer Research. 69(13). 5374–5382. 12 indexed citations

17.

Zhang, Hui, et al.. (2005). Aberrant splicing of cables gene, a CDK regulator, in human cancers. Cancer Biology & Therapy. 4(11). 1211–1215. 13 indexed citations

18.

Han, Won Kon, Chin‐Lee Wu, M. Dror Michaelson, et al.. (2005). Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell Carcinoma. Journal of the American Society of Nephrology. 16(4). 1126–1134. 154 indexed citations

19.

Jiang, Zhong, Bruce A. Woda, Chin‐Lee Wu, & Ximing J. Yang. (2004). Discovery and Clinical Application of a Novel Prostate Cancer Marker a-Methylacyl CoA Racemase (P504S). American Journal of Clinical Pathology. 122(2). 275–289. 76 indexed citations

20.

Jiang, Zhong, Bruce A. Woda, Chin‐Lee Wu, & Ximing J. Yang. (2004). Discovery and Clinical Application of a Novel Prostate Cancer Marker. American Journal of Clinical Pathology. 122(2). 275–289. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact